venBio Global Strategic Fund, L.P. — Form D/A
venBio Global Strategic Fund, L.P. of SAN FRANCISCO, CA, a pooled investment fund, filed a Form D amendment with the SEC on 2012-10-31. The offering totals $177.5M, of which $177.0M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2012-10-31
- Form: D/A
- Accession: 0001504130-12-000001
- Industry: Pooled Investment Fund
- Exemptions: 06, 3C, 3C.1, 3C.7
- Total offering: $177.5M
- Amount sold: $177.0M
- Remaining: $500K
- Investors: 4
- Date of first sale: 2010-11-03
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-150376
Issuer
- Name: venBio Global Strategic Fund, L.P.
- CIK: 0001504130
- Entity type: Limited Partnership
- Jurisdiction: CAYMAN ISLANDS
- Incorporated: 2010
- Address: 1700 OWENS STREET, SUITE 595, SAN FRANCISCO, CA, 94158
- Phone: 415-522-0100
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Kurt von Emster | Director | Redwood City, CA |
| Corey Goodman | Director | Cambridge, MA |
| Robert Adelman | Director | San Francisco, CA |
| Paul Brooke | Director | San Francisco, CA |
| n/a venBio Global Strategic GP, L.P. | Director | San Francisco, CA |
| n/a venBio Global Strategic GP, Ltd. | Director | San Francisco, CA |
Other filings by this issuer (3)
More